Skip to main content

Hidden DNA' in The Blood Could Help Some Cancer Patients Avoid Chemo

In this article i will be discussing about the chemotherapy & its alternative advanced , aspect in cancer treatment 

 Chemotherapy is an incredible tool for annihilating cancer cells, but our regular cells end up in the crossfire, which can result in life-altering side effects.


Chemotherapy or chemo for short is not always required for successful treatment either, but how to tell if someone requires it can be both an art and a science. Now, a new study provides clinicians with a technique that has already helped some stage II colon cancer patients avoid chemo, with no change to their clinical outcomes.

The technique employed in this new study uses a type of DNA called circulating tumor DNA (ctDNA). This is pretty self-explanatory – it's small sections of fragmented DNA from tumors that are circulating around in the blood stream. Importantly, they are not part of a tumor cell however, just the DNA from the tumor by itself .

The presence of ctDNA in the bloodstream post-surgery predicts the risk of cancer recurrence.

The new study has taken this knowledge a step further, however. Looking at stage II colon cancer, it's the first clinical study showing that a ctDNA 'guided approach' after surgery can significantly benefit the patients.

"Stage II colon cancer presents a unique challenge," explains Johns Hopkins gastroenterologist Anne Marie Lennon.

"In stage I colon cancer, patients do not receive chemotherapy because their prognosis for survival is over 90 percent. The risk of discomfort and toxicities from the therapy outweigh the benefits it can provide. On the other hand, every stage III colon cancer patient currently receives chemotherapy because the risk of relapse is high."
In stage II colon cancer, the cancer has spread through the muscle layers of the colon wall, but has yet to spread to other organs. In this case, the patient will undergo surgery to remove the tumor, but then the clinician will have to make a choice on whether they also undergo chemotherapy afterwards.

We know that approximately 75 percent of people with stage II colon cancer don't require chemotherapy after surgery, but about 25 percent do. Working out which patients will benefit the most from chemo is incredibly important, and getting it wrong can be deadly.

Currently, there are a number of features a tumor might have that could prompt the doctor to book chemotherapy – for example, if the tumor looks abnormal under the microscope, or if the cancer has broken all the way through into other tissue.

But this new study has shown that this method isn't foolproof, and many cancer patients might be getting chemotherapy when they don't need it.

Between 2015 and 2019, 455 patients with type II colon cancer were recruited to the study. From this, 302 were assigned to the ctDNA guided approach, while the rest received standard care. The patients were followed up with after around 37 months, meaning the study had data on the patients for over three years .

Both the standard management and the guided treatment had similar rates of survival, and no recurrence of the cancer (92.4 vs 93.5 percent) within the study period. However, the big difference was the amount of chemotherapy that was administered. In the standard treatment group, 27.9 percent of patients underwent chemo, while in the ctDNA guided treatment group only 15.3 had to.

That's almost double the number of patients who underwent chemotherapy, for no increase in survival or decrease in tumor recurrence.

"A ctDNA-guided approach to stage II colon cancer reduced adjuvant chemotherapy use without compromising recurrence-free survival," the researchers – lead by Walter and Eliza Hall Institute gastrointestinal oncologist Jeanne Tie – wrote in their new paper.

"The low recurrence rate in ctDNA-positive patients who received chemotherapy suggests a survival benefit from adjuvant therapy."

The researchers hope ctDNA could also be a helpful indicator for how to treat other types of cancer and other stages of colon cancer, and the team is already working on early stage pancreatic and stage III colon cancer to see if ctDNA can help there too.

"We have an opportunity to change clinical practice," says biomedical engineer Joshua Cohen, one of the researchers from Johns Hopkins University School of Medicine.

"Using ctDNA to guide treatment, a stage II colon cancer patient who is negative for ctDNA has a lower chance of cancer recurrence than the average stage I colon cancer patient."




Popular posts from this blog

Homeopathy and Cancer Treatment: A Complementary Approach

Hello, I'm Vishnu, a passionate homeopathy practitioner dedicated to exploring the full potential of holistic health. As the field of complementary and alternative medicine continues to evolve, homeopathy has gained attention for its gentle and individualized approach to healing. Today, I want to shed light on how homeopathy can serve as a supportive option for individuals facing cancer, while also emphasizing the importance of informed decision-making. Homeopathy, based on the principle of "like cures like," involves using highly diluted substances to stimulate the body’s natural healing response. For many, this gentle method offers a sense of empowerment and comfort, particularly in challenging health situations such as cancer. Though homeopathy is not promoted as a stand-alone cancer treatment, it can play a valuable role in supporting patients alongside conventional therapies. Individuals undergoing conventional cancer treatments like chemotherapy and radiation often ...

Homeopathy & Smoking: A Natural Way to Beat the Cravings

|  Why is Smoking So Hard to Quit?   Hey there! I’m Vishnu, a  homeopathy practioner and researcher, always curious about how natural healing can make a difference. Smoking is one of the toughest habits to quit A transient surge of endorphins in the reward circuits of the brain causes a slight, brief euphoria when nicotine is administered. This surge is much briefer than the "high" associated with other drugs. However, like other drugs of abuse, nicotine increases levels of the neurotransmitter dopamine in these reward circuits , which reinforces the behavior of taking the drug. Repeated exposure alters these circuits' sensitivity to dopamine and leads to changes in other brain circuits involved in learning, stress, and self-control. For many tobacco users, the long-term brain changes induced by continued nicotine exposure result in addiction, which involves withdrawal symptoms when not smoking, and difficulty adhering to the resolution to quit. We all know smoking is har...

Homeopathy vs. Conventional Medicine: Can They Work Together?

  Hello everyone, I’m  Vishnu , a homeopathic medical student passionate about exploring how different healing approaches can work together. Today, let’s talk about a topic that often sparks debate: Homeopathy and Conventional Medicine   – Are they rivals, or can they complement each other?   Understanding the Two Systems   Before we jump to conclusions, let’s get the basics right.   - Conventional Medicine (Allopathy) is what most people are familiar with—fast-acting drugs, surgeries, and treatments backed by extensive clinical trials. It focuses on symptom suppression and is highly effective in emergencies, infections, and life-threatening conditions.   - Homeopathy, on the other hand, follows the principle of "like cures like" and individualized treatment. It aims to stimulate the body's natural healing response using highly diluted substances. Homeopathy is widely used for chronic diseases, allergies, autoimmune disorders, and even mental hea...